AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2013

Jul 23, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2013-07-23

Reporting Person: KARSEN PERRY A (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct

Footnotes

F1: Mr. Karsen does not own shares in his individual capacity. He is an executive vice president of Celgene Corporation ("Celgene"), which is the parent company of Celgene European Investment Company LLC ("CEIC"). CEIC is a reporting person and has filed a Form 3 reporting its ownership. Mr. Karsen disclaims beneficial ownership of CEIC's shares, except to the extent of his pecuniary interest therein.